Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2008-06-30
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program
NCT00236210
Implementation of a Structured Lifestyle Program in Primary Care. Changes in Lifestyle Habits and Cardiovascular Risk.
NCT03681002
Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
NCT00291824
Cardiovascular Health And Risk Modification in Family Health Teams
NCT00787306
CVD Risk Reduction Trial
NCT00473785
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Behavioral
CVD risk profile
Cardiovascular risk assessment and behavioral counselling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CVD risk profile
Cardiovascular risk assessment and behavioral counselling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have provided informed consent
* Recent (past 6 months) fasting lipid profile results in the medical charts
Exclusion Criteria
* Subject is not literate in either French or English
* Subject does not have easy and regular access to the Internet
* Exercise or weight loss are contra-indicated for medical reasons
30 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Steven Grover, MD
Medical Director McGill Comprehensive Health Improvement Program
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steven Grover, MD
Role: PRINCIPAL_INVESTIGATOR
McGill Cardiovascualr Health Improvement Program
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McGill Cardiovascular Health Improvement Program
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Web site used by study participants
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLIN-08001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.